Healthpeak Properties vs Ventas
DOC and VTR side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DOC and VTR compare
Ventas is the larger company, worth 3.3 times as much as Healthpeak Properties ($43.5B against $13.1B).
On earnings, Healthpeak Properties is cheaper: it trades at 54.4× trailing earnings, against 157× for Ventas.
Ventas grew revenue faster over the last twelve months (21.5% versus 5.5% for Healthpeak Properties).
Both pay dividends: Healthpeak Properties yields 6.4% and Ventas 2.4%.
Healthpeak Properties scores higher on the StockData Score (8 against 7 for Ventas), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DOC | VTR |
|---|---|---|
| Size and price | ||
| Market cap | $13.1B | $43.5B |
| Share price | $19.03 | $84.80 |
| Change, 1 year | 8.2% | 21.5% |
| Change, 5 years | −44.4% | 57.1% |
| Beta (5Y) | 0.73 | 0.56 |
| Employees | 411 | 542 |
| StockData Score | ||
| Total score | 8 (better) | 7 |
| Valuation score | 1 | 1 |
| Growth score | 4 (better) | 3 |
| Performance score | 0 | 0 |
| Health score | 0 | 2 (better) |
| Dividend score | 3 (better) | 1 |
| Valuation | ||
| P/E | 54.4× (better) | 157× |
| P/S | 4.4× (better) | 6.8× |
| P/B | 1.7× (better) | 3.0× |
| EV/EBITDA | 7.0× (better) | 18.6× |
| Fair value | $17.22 | $39.33 |
| Margin of safety | −10.5% (better) | −116% |
| Growth | ||
| Revenue growth (TTM) | 5.5% | 21.5% (better) |
| Revenue growth, 5Y average | 11.4% (better) | 9.0% |
| Net income growth (TTM) | 47.5% | – |
| EPS growth (TTM) | 45.8% (better) | 25.6% |
| EPS growth, 5Y average | −33.5% | −14.3% (better) |
| Profitability | ||
| Net margin | 8.2% | – |
| Return on equity | 3.1% | – |
| Financial health | ||
| Debt / equity | – | 0.02 |
| Net debt / EBITDA | – | 0.03 |
| Altman Z-score | 0.78 | 1.65 (better) |
| Piotroski F-score | 4 | – |
| Dividends and buybacks | ||
| Dividend yield | 6.4% (better) | 2.4% |
| Payout ratio | 348% | – |
| Years of dividend growth | 1 | 1 |
| Dividend growth, 5Y average | −3.8% | −2.2% (better) |
| Buyback yield | 0.77% (better) | −8.8% |
| Shareholder yield | 7.2% (better) | −6.4% |
| Ownership | ||
| Held by institutions | 95.9% | 102% |
| Held by insiders | 0.36% | 0.46% |
| Insider net buying, 12 months | −$214K (better) | −$19.0M |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 3.4% | 3.2% |
Go deeper
- DOC stock overview
- DOC income statement
- DOC valuation and score
- VTR stock overview
- VTR income statement
- VTR valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.